HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.71
Day range
$0.67 - $0.73
Year range
$0.62 - $1.70
Market cap
35.68M USD
Avg Volume
825.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 19.07M | 742.51% |
Operating expense | 6.67M | 5.82% |
Net income | -16.29M | -16.17% |
Net profit margin | -85.42 | 86.21% |
Earnings per share | — | — |
EBITDA | -1.59M | 88.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.76M | 69.39% |
Total assets | 133.69M | 79.08% |
Total liabilities | 141.79M | 164.12% |
Total equity | -8.10M | — |
Shares outstanding | 52.50M | — |
Price to book | -4.44 | — |
Return on assets | -3.61% | — |
Return on capital | -69.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -16.29M | -16.17% |
Cash from operations | -17.50M | -27.96% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -285.00K | -9,400.00% |
Net change in cash | -17.78M | -29.93% |
Free cash flow | -14.80M | -113.09% |
About
Founded
2016
Headquarters
Website
Employees
64
